Search
Streptococcal Infections
go.drugbank.com/conditions/DBCOND0034240Drugs: CloxacillinSynonyms: Bacterial infection due to unspecified streptococcusStaphylococcal Infection
go.drugbank.com/conditions/DBCOND0034598Synonyms: Bacterial infection due to unspecified staphylococcusAlcohol Withdrawal Associated Autonomic Hyperactivity
go.drugbank.com/conditions/DBCOND0052442Synonyms: [X]Mental and behavioral disorders due to use of alcohol: withdrawal state with delirium (disorder)Hansen's Disease
go.drugbank.com/conditions/DBCOND0064479Synonyms: Infection due to Mycobacterium lepraeNorelgestromin
go.drugbank.com/drugs/DB06713ApprovedInvestigational[L63816] Combined hormonal contraceptives containing norelgestromin lower the risk of pregnancy primarily by suppressing ovulation.
Mixtures: EVRA TRANSDERMAL PATCH (6 mg/600 mcg), Gwyn LoCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesFlurpiridaz F-18
go.drugbank.com/drugs/DB18773Approved[A264519] Flurpiridaz F-18 is an analog of pyridaben, a mitochondrial complex 1 (MC-1) inhibitor.[L51659]
Synonyms: 2-tert-butyl-4-chloro-5-((4-((2-(18f)fluoroethoxy)methyl)phenyl)methoxy)pyridazin-3(2h)-one, 2-tert-butyl-4-chloro-5-[[4-(2-(18F)fluoranylethoxymethyl)phenyl]methoxy]pyridazin-3-one2-(5-fluoro-pentyl)-2-methyl-malonic-acid
go.drugbank.com/drugs/DB16029Investigational2-(5-fluoro-pentyl)-2-methyl-malonic-acid is under investigation in clinical trial NCT00696943 (18F ML-10 for Early Detection of Response of Brain Metastases to SRS).
Synonyms: 2-(5-fluoro-pentyl)-2-methyl-malonic-acidTeclistamab
go.drugbank.com/drugs/DB16655ApprovedInvestigationalcells to promote T cell–mediated cytotoxicity. … [A253587] Teclistamab consists of an anti-BCMA arm and an anti-CD3 arm connected via two interchain disulfide bonds,[A253587, L43622] allowing the drug to recruit CD3-expressing T cells to BCMA-expressing
Categories: Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engagerKappadione
go.drugbank.com/drugs/DB09332ApprovedKappadione is a Vitamin K derivative (chemically, it is menadiol sodium diphosphate), previously approved by FDA prior to 1982 and marketed by Lilly Marketing for this drug has been discontinued and is … It has been found to have carcinogenic potential in mammalian cells as well as cytotoxic properties [L1544].